Locations
Oklahoma City, OK, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2015
Progentec Diagnostics, Inc. focuses on developing innovative diagnostic solutions for autoimmune diseases, particularly systemic lupus erythematosus and multiple sclerosis. Their product pipeline includes the ai SLE® DX family of tests, which utilize proteomics and digital health technologies to provide proactive care and monitoring for patients. By combining proprietary blood biomarkers with remote digital monitoring, Progentec aims to empower clinicians and patients alike, improving health outcomes and reducing costs. The company has established a significant presence in the market, with over 120,000 users engaging with their Lupus Corner platform for research updates and health management tools.
Something looks off?